Filing Flows › Chemed (CHE) › Q1 2026
Chemed (CHE) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 28, 2026
Chemed (CHE) reported revenue of $658M for the first quarter 2026 (Q1 2026), +2% from a year earlier and +3% from the quarter before. Operating margin was 12.9%, net earnings $66.3M (10.1% of revenue).
Chemed, Q1 2026: revenue $658M (+2% year over year), operating margin 12.9%, net earnings $66.3M, operating cash flow $88.2M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $658M | +3% | +2% |
| Operating profit | $84.6M | -16% | -11% |
| Net earnings | $66.3M | -14% | -8% |
| Operating cash flow | $88.2M | -34% | +169% |
| Free cash flow | $50.4M | -57% | +165% |
What changed
Revenue was $657.5M in Q1 2026, up 2% year over year and up 3% from the previous quarter. VITAS was the largest line at 64% of revenue. VITAS added $12.6M year over year (up 3%), 119% of the total change. Roto-Rooter declined 1%.
Operating profit was $84.6M, a 12.9% margin (down 1.8 points year over year). Operating profit fell $10.2M even though revenue rose $10.6M versus Q1 2025, so costs grew faster than sales. Total costs grew 4% against revenue growth of 2%. Net earnings were $66.3M, down 8% year over year. The effective tax rate was 25.4%.
Operating cash flow was $88.2M (up 169% year over year), 133% of net earnings. Non-cash charges added back $16.9M of depreciation and amortization. Working capital and other items added $5.0M. Capital expenditures of $37.9M left free cash flow of $50.4M.
Questions
What was Chemed's revenue in the first quarter 2026?
Chemed (CHE) reported revenue of $658M for the first quarter 2026 (Q1 2026), +2% from a year earlier and +3% from the quarter before.
Was Chemed profitable in the first quarter 2026?
Operating profit was $84.6M (12.9% of revenue) and net earnings $66.3M.
Source: Chemed 10-Q on SEC EDGAR.